Abstract
Aims/hypothesis. This study was designed to determine whether inhibition of formation of AGE and advanced lipoxidation end-products (ALE) is a mechanism of action common to a diverse group of therapeutic agents that limit the progress of diabetic nephropathy. We compared the effects of the ACE inhibitor enalapril, the antioxidant vitamin E, the thiol compound lipoic acid, and the AGE/ALE inhibitor pyridoxamine on the formation of AGE/ALE and protection against nephropathy in streptozotocin diabetic rats.
Original language | English |
---|---|
Pages (from-to) | 1385-1395 |
Number of pages | 11 |
Journal | Diabetologia |
Volume | 47 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2004 |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Internal Medicine